Neutrophil chemotaxis plays an essential role in innate immunity, but the underlying cellular mechanism is still not fully characterized. Here, using a small-molecule functional screening, we identified NADPH oxidase-dependent reactive oxygen species as key regulators of neutrophil chemotactic migration. Neutrophils with pharmacologically inhibited oxidase, or isolated from chronic granulomatous disease (CGD) patients and mice, formed more frequent multiple pseudopodia and lost their directionality as they migrated up a chemoattractant concentration gradient. Knocking down NADPH oxidase in differentiated neutrophil-like HL60 cells also led to defective chemotaxis. Consistent with the in vitro results, adoptively transferred CGD murine neutrophils showed impaired in vivo recruitment to sites of inflammation. Together, these results present a physiological role for reactive oxygen species in regulating neutrophil functions and shed light on the pathogenesis of CGD.
chronic granulomatous disease | innate immunity | NADPH oxidase N eutrophils are major players in innate immunity and constitute the first line of host defense against invading bacteria and other pathogens. In response to inflammatory stimuli, neutrophils migrate from the blood to infected tissues, where they protect their host by engulfing, killing, and digesting invading bacterial and fungal pathogens. Conversely, excessive neutrophil accumulation can be detrimental to the system. Hence, neutrophil recruitment in response to inflammatory stimuli needs to be well controlled.
Neutrophils are recruited to the site of infection by responding to a variety of chemokines, leukotrienes, complement peptides, and some chemicals released by bacteria directly, such as peptides bearing the N-formyl group (i.e., formyl-peptides). Neutrophil chemotaxis is mediated by heterotrimeric guanine nucleotidebinding regulatory proteins (G protein)-coupled receptors (GPCRs). One essential downstream target of GPCR is PtdIns (3, 4, 5) P3. Chemoattractants bind receptors on cell membrane and induce the dissociation of a specific G protein into α-and βγ-subunits. Released βγ-subunits initiate accumulation of PtdIns (3, 4, 5) P3 and subsequent actin polymerization at the leading edge of chemotaxing cells. Earlier studies have suggested that PtdIns (3, 4, 5) P3 plays the essential role of a cellular compass, localizing to the leading edge of pseudopodia, mediating direction sensing during chemotactic migration and cell polarity (1) (2) (3) (4) . However, several recent studies have shown that loss of PI3K and reduced PtdIns (3, 4, 5) P3 level lead to decreased polarity, but does not affect the ability of the cell to sense chemoattractant gradients. In both human neutrophils (5, 6) and Dictyostelium (7-9), chemotaxis could occur independently of the PI3K-dependent actin polymerization, although it was somewhat delayed, suggesting extra pathways are required for neutrophil chemotaxis.
To identify these putative signal-induced chemotactic pathways, we conducted a functional screening for chemical compounds that disrupt neutrophil directionality. We have identified NADPH oxidase dependent reactive oxygen species (ROS) as key regulators of neutrophil chemotaxis. Neutrophils with pharmacologically inhibited NADPH oxidase, or isolated from chronic granulomatous disease (CGD) patients and mice, displayed more frequent multiple pseudopodia formation and impaired directionality during chemotaxis. This finding provides a cellular mechanism for CGD pathogenesis and might lead to development of new therapeutic strategies for this disease.
Results
Screening for Inhibitors of Neutrophil Chemotaxis. The screening was performed using an EZ-TAXIScan chemotaxis device in which a stable chemoattractant gradient was formed in a 260-μm-wide channel (Fig. S1A) . Freshly purified human primary neutrophils migrated robustly up the gradient and most cells crossed the channel in 20 min (Fig. S1B) . A Tocris screening library containing 386 biologically active compounds was used for screening (Table S1 ). To achieve the maximal inhibition of each targeted pathway in the primary screening, we treated neutrophils with each drug at a concentration equivalent to 10 times the IC 50 of the drug. Although most compounds did not affect neutrophil chemotaxis (Dataset S1), 83 compounds displayed inhibitory effects. (The video files for each compound will be released to a public database after the publication of this article.) The inhibitory effects were elicited via a variety of mechanisms (Table S1 ), such as induction of cell death (Dataset S2), complete inhibition of polarization and migration, slow migration, and impairment of directionality. Selected compounds from the primary screen were then used at 0.2 to 10 times the IC 50 in a secondary screening (Dataset S3). Most positive compounds identified from the primary screening showed the same inhibitory effect at lower concentrations, suggesting that the drug-induced phenotype changes were most likely caused by specific inhibition of each targeted pathway. H.H., K.K.S., and J.S. contributed equally to this work. 2 To whom correspondence should be addressed. E-mail: hongbo.luo@childrens.harvard. edu.
This article contains supporting information online at www.pnas.org/cgi/content/full/ 0914351107/DCSupplemental.
We focused on the 12 compounds that led to impaired directionality, but did not inhibit neutrophil migration completely (Figs. S2 and S3). Five of these drugs are compounds that inhibit microtubule polymerization, which is consistent with recent reports indicating that microtubules negatively regulate uropod signaling and enhance directional sensing in neutrophils (10, 11) . Interestingly, the most dramatic inhibitory effect was induced by diphenyleneiodonium chloride (DPI), a well characterized and commonly used flavoprotein inhibitor that was known to suppress activity of NADPH oxidase and NOS (12) (13) (14) . As neutrophil chemotaxis was not affected by other NOS inhibitors (e.g., 7-nitroindazole, L-NIO dihydrochloride, 1-[2-(trifluoromethyl) phenyl]imidazole, 2-amino-5,6-dihydro-6-methyl-4H-1,3 thiazine, ethylisothiourea, S-isopropylisothiourea hydrobromide, NGmethyl-L-arginine, nω-nitro-l-arginine methyl ester, nω-nitro-Larginine, and L-canavanine) or NO donors (3-morpholinosydnonimine, s-nitrosoglutathione, and spermine NONOate; Dataset S1), it is most likely that the effect of DPI on neutrophil chemotaxis was mediated by the inhibition of NADPH oxidase, suggesting that chemoattractant elicited ROS production might play a role in regulating neutrophil chemotactic migration.
ROS Are Physiological Regulators of Neutrophil Chemotactic Migration.
We further investigated the effect of DPI on neutrophil directional migration using a transwell migration system. Cells were plated on transwell filters and induced to migrate in response to Fig. 1 . Pharmacological inhibition of NADPH oxidase-mediated ROS production in human neutrophils leads to more frequent formation of multiple pseudopodia and reduced chemotaxis efficiency. (A) Inhibition of NADPH oxidase decreases transwell migration of human neutrophils. Human neutrophils were left untreated or pretreated with 50 μM DPI for 30 min at 37°C, and then allowed to migrate in response to the indicated concentration of fMLP. Percentage of cells that migrated into the bottom well was recorded. Data shown are means ± SD from n = 3 wells, from one experiment representative of three. (*P < 0.05 vs. untreated neutrophils.) (B) Chemotaxing NADPH oxidase-inhibited human neutrophils display multiple pseudopodia more frequently, but do not show difference in cell speed. Representative images of human neutrophils treated (Right) or not treated (Left) with 50 μM DPI and allowed to chemotax in response to a chemoattractant gradient generated by addition of 1 μL of 100 nM fMLP in the EZ-TAXIScan device. White arrowheads specify pseudopodia in the cells. Percentage of cells that display multiple pseudopodia (bottom left, n = 20 cells; Fisher 2 × 2 test, *P < 0.05 vs. untreated) and migration speed (bottom right, mean ± SD from n = 20 cells; Student t test, *P > 0.05 vs. untreated) during the course of the EZ-TAXIScan chemotaxis assay in the DPI-treated or untreated case were quantified as described in Experimental Procedures. (C) Inhibition of NADPH oxidase leads to multiple pseudopod formation and defective directionality in fMLP-, LTB4-, and IL-8-mediated chemotaxis. Neutrophil chemotaxis in response to addition of 100 nM fMLP, 100 nM LTB4, or 10 nM IL-8 (1 μL each), with 50 μM DPI treatment (or without treatment), was analyzed (n = 20 cells) for directionality, upward directionality, and percentage of neutrophils displaying multiple pseudopodia as described earlier (n = 20 cells, *P < 0.05). (D) Pharmacological agents that inhibit ROS production cause chemotaxis defect in human neutrophils. fMLP-induced ROS production (Fig. S5 Top) in human neutrophils (5 × 10 5 ) pretreated with sinomenine (10 μM), DPI (50 μM), EHNA hydrochloride (40 μM), or LE135 (14 μM), or without pretreatment, was evaluated by stimulating neutrophils with 100 nM fMLP and monitoring chemiluminescence (for 1 s) every 7 s for 280 s, in the presence of 50 μM luminol and 0.8 U HRP in a luminometer at 37°C. Data represent maximal chemiluminescence in drug-treated neutrophils normalized to maximal chemiluminescence in untreated neutrophils (mean ± SD, n = 3 wells from one experiment representative of three). Drugtreated (and untreated) neutrophils were also exposed to an fMLP gradient generated by addition of 100 nM fMLP (1 μL) in the EZ-TAXIScan device. Images and cell tracks of migrating neutrophils were evaluated for directionality, upward directionality and percentage of neutrophils displaying multiple pseudopodia as described earlier (n = 20 cells; *P < 0.05). (E) H 2 0 2 treatment of NADPH oxidase-inhibited human neutrophils rescues defect in pseudopod formation and chemotaxis. Human neutrophils were pretreated with 50 μM DPI (or without) and then treated with (or without) 100 μM H 2 0 2 for 5 min and then allowed to chemotax in response to a fMLP gradient in the EZ-TAXIScan device as described earlier. Migrating neutrophils were evaluated (n = 20 cells; *P < 0.05 vs. DPItreated neutrophils) for directionality, upward directionality, and percentage of neutrophils displaying multiple pseudopodia as described earlier.
chemoattractant added to wells beneath the filters. The migration of neutrophils to these lower wells requires 2D chemotaxis on top of the filter (toward the holes), followed by migration through the holes into the bottom well of chemoattractant. The number of cells in the bottom well was then used to calculate percentage of cells migrated. Consistent with the EZ-TAXIScan results, treatment with DPI significantly inhibited neutrophil migration into the lower wells (Fig. 1A) . To take a closer look at the morphological changes elicited by DPI treatment, multiple pseudopod formation was measured in chemotaxing neutrophils. We observed that DPI-treated neutrophils showed multiple pseudopodia much more frequently compared with untreated neutrophils, although the migration speed of these two populations was essentially the same (Fig. 1B) . The DPI-induced inhibitory effect appeared not to be specific to chemotaxis-elicited by chemoattractant N-formyl-methionyl-leucyl-phenylalanine (fMLP), which was used for the initial screening. Treatment with DPI also significantly inhibited chemotaxis elicited by leukotriene B4 (LTB4) and IL-8, suggesting that DPI might block a general pathway in directional migration (Fig. 1C) . Interestingly, IL-8-mediated chemotaxis was more resistant to DPI treatment compared with fMLP and LTB4. It seems that this is not a sensitivity issue, as we checked several chemoattractant concentrations and the effect of DPI treatment on IL-8-induced chemotaxis is always weaker (Fig. S4 ). This effect might be caused by relatively lower ROS production in IL-8-treated cells. Chemical inhibitors often have multiple targets. DPI may also inhibit other flavincontaining enzymes. To ensure that the DPI-induced neutrophil chemotaxis defect was indeed caused by inhibition of NADPH oxidase, we examined another NADPH oxidase inhibitor, sinomenine (15). Similar to DPI, sinomenine induced multiple pseudopodia in chemotaxing neutrophils and significantly reduced chemotaxis efficiency. Interestingly, two of the compounds identified from the initial screening, EHNA hydrochloride and LE135, previously known as adenosine deaminase inhibitor and retinoic acid antagonist, respectively, also drastically suppressed chemoattractant-elicited NADPH oxidase activation, again indicating the involvement of ROS in chemotactic migration ( Fig. 1D and Fig. S5 ). Further supporting this hypothesis is the observation that DPI-induced chemotaxis defects were partially rescued by including H 2 O 2 in chemotaxis buffer (Fig. 1E) . Although DPI is a well known and commonly used NADPH oxidase, its effect on cell migration may be mediated by other undefined mechanisms. To definitely prove that the DPI-induced neutrophil chemotaxis defect is at least partially caused by inhibition of NADPH oxidase, we next explored neutrophil chemotaxis using a CGD mouse in which gp91 subunit of NADPH oxidase holoenzyme was deleted and thus chemoattractant-elicited superoxide production was completely abolished (Fig. 2A) . Similar to chemical inhibition, neutrophils isolated from these mice displayed multiple pseudopods (Fig. 2C ) and reduced chemotaxis efficiency ( Fig. 2 B and D) . Consistently, neutrophils isolated from the CGD mice also displayed a migration defect in the transwell assay compared with WT neutrophils (Fig. 2E) . Finally, we investigated the chemotaxis of neutrophil-like differential HL60 cells in which the p22 phox subunit of NADPH oxidase was knocked down by a specific siRNA, and essentially the same results were observed ( Fig. 2 F-H) . Collectively, all these results suggest that signal-induced NADPH oxidase-mediated ROS production plays an essential role in regulating neutrophil chemotaxis.
Neutrophils Isolated from CGD Patients Also Show Severe Chemotaxis
Defect. To further explore the physiological and clinical significance of the regulation of neutrophil migration by ROS, we examined chemotaxis behaviors of neutrophils isolated from a CGD patient that contain mutated alleles of the gene encoding gp91 phox . As expected, neutrophils from the CGD patient displayed impaired chemoattractant-elicited ROS production in comparison with neutrophils from a healthy volunteer (Fig. 3A) . The ROS peak in these neutrophils is significant, but is much smaller than that in the WT neutrophils. Adhesion-induced ROS production in the absence of chemoattractant was also abolished in the CGD neutrophils. The CGD neutrophils displayed a striking chemotaxis defect, showing lack of directionality, more frequent formation of multiple pseudopodia, and slow migration toward the direction of higher chemoattractant (Fig. 3B) . It is noteworthy that the CGD patient in this study was receiving IFN-γ treatment. Nevertheless, it is unlikely that the observed neutrophil chemotaxis defect was a result of this treatment, as IFN-γ-treated WT neutrophils showed normal directionality during chemotaxis. Collectively, these results suggest that the defective neutrophil chemotaxis might be contributive to the compromised bactericidal activity in CGD patients, providing a cellular mechanism for CGD pathogenesis.
CGD Mice Display Impaired in Vivo Neutrophil Recruitment. Our in vitro experiments showed that neutrophils depleted of ROS display reduced chemotaxis efficiency. We next investigated whether this defect in chemotaxis will lead to impaired neutrophil recruitment to sites of inflammation in live mice using a murine acute peritoneal inflammation (i.e., peritonitis) model. To compare neutrophil recruitment under exactly the same environment, an adoptive transfer experiment was conducted (Fig. S6 ). We labeled in vitro purified CGD neutrophils with intracellular fluorescent dye 5-(and 6-) carboxyfluorescein diacetate succinimidyl esters (CFSE; green) and WT neutrophils with another dye, 5-(and 6-) chloromethyl SNARF-1 acetate (red), or vice versa. The mixed (1:1) population was i.v. injected into a WT recipient mouse 2.5 h after the i.p. thioglycolate (TG) injection. By doing this, variability caused by difference in inflammatory environment in each individual recipient mouse will be eliminated. CGD (green) and WT (red) neutrophils (B) Neutrophils from the CGD patient or healthy volunteer were exposed to a chemoattractant gradient generated by addition of 100 nM fMLP (1 μL) in the EZ-TAXIScan device and imaged every 0.5 min for 20 min. Cell tracks of migrating neutrophils (n = 20) were traced from the captured images, realigned to start from the same point (0,0), and plotted (Top). Images of chemotaxing neutrophils from the CGD patient or healthy volunteer are shown (Middle). White arrowheads specify pseudopodia in the cells. Neutrophils were evaluated (n = 20 cells, *P < 0.01 vs. WT neutrophils) for directionality, upward directionality, percentage of neutrophils displaying multiple pseudopodia, and migration speed as described earlier (Bottom).
were identified by their unique fluorescent labels. As we measured neutrophil numbers at 4 h after the TG injection, when neutrophil death is minimal, the ratio of CGD neutrophils to WT neutrophils most likely reflected their relative capability to migrate to the inflamed peritoneal cavity. Consistent with the in vitro results, we detected a much reduced peritoneal recruitment of CGD neutrophils compared with WT neutrophils (Fig. 4A) . A similar effect was also detected in a murine air pouch model in which recruitment of adoptively transferred neutrophils to a preformed air pouch was induced by TNF-α (Fig. 4B) . These results further support the conclusion that ROS generated by NADPH oxidase are key physiological regulators of actin dynamics in neutrophils.
Discussion
In this study, using an unbiased screening approach, we have identified ROSs as essential players for modulating neutrophil chemotaxis. Chemotaxis is a process in which cells sense and move up a gradient of molecules (chemoattractants). It plays a central role in the regulation of host defense and inflammatory reactions by recruiting circulating effector leukocytes, including neutrophils, monocytes, and effector T cells, to the sites of injury or infection. During chemotaxis, chemoattractants elicit a number of changes in neutrophils. These include a localized polymerization of F-actin at the site of cell cortex closest to the chemoattractant source, a morphological change characterized by cell elongation, the formation of new lamellipodia or pseudopods at the leading edge, and the forward protrusion of the leading edge followed by retraction of posterior of the cell. We have found that neutrophils with inhibited ROS production that were isolated from CGD patients or mice or pharmacologically/ siRNA-treated to inhibit the NADPH oxidase complex displayed defective migration. These neutrophils formed more frequent multiple pseudopodia and lost their directionality as they migrated up a chemoattractant concentration gradient.
CGD is an inherited disorder characterized by recurrent bouts of infection as well as chronic inflammation with granuloma formation. Consistently, neutrophil recruitment to sites of inflammation is dramatically elevated in the CGD mice (16). This hyperinflammatory phenotype is likely caused by dysfunctional kynurenine pathway of tryptophan catabolism (17) and suppression of ROS-induced deactivation of proinflammatory chemokines such as C5a, fMLP (18), LTB4 (19), and IL8 (20). At the sites of infection, the inability of CGD neutrophils to produce ROS in response to chemoattractant stimulation may contribute to the impaired bactericidal activity of these cells. Our discovery that depletion of signal-elicited ROS production in fact inhibits neutrophil chemotactic migration provides another cellular mechanism for CGD pathogenesis and might lead to development of new therapeutic strategies for this disease.
How is chemotactic migration regulated by ROSs? ROSs have been identified as important second messengers that can regulate intracellular signal transduction under a variety of physiological and pathophysiological conditions. This has been shown to occur predominantly via oxidation of thiols (-SH) on protein cysteine (via tail vein) into WT mice that have been challenged with 1 mL 3% TG for 2.5 h. Peritoneal fluids were harvested 1.5 h after the injection of cell mixture. The amount of adoptively transferred neutrophils recruited to the peritoneal cavity was analyzed using a BD FACSCanto II flow cytometer (Becton Dickinson) and BD FACSDiva software. Relative recruitment of neutrophil was calculated as the ratio of indicated populations in the peritoneal cavity. (B) Recruitment of adoptively transferred neutrophils to a preformed air pouch. The dorsal air pouch was generated on WT recipient mice as described in Experimental Procedures. Neutrophil recruitment to the pouch was induced by TNF-α, which was directly injected into the pouch 2.5 h before the neutrophil injection. The pouch was flushed 1.5 h after the injection of cell mixture. The relative recruitment of WT and CGD neutrophil was calculated as described earlier.
residues, resulting in reversible protein posttranslational modifications such as glutathionylation, disulfide bond formation, and sulfenic acid formation. Many of these modifications control signal transduction by altering functionality/activity of the protein involved. Redox regulation of numerous proteins such as Ras, protein tyrosine kinases (Src kinases), and protein tyrosine phosphatases have been reported and are known to alter protein functions. PTEN has also been identified as a target of ROSs (21-23). ROSs can also directly regulate actin polymerization via modifying G-actin monomers (21-23). In addition, the NADPH oxidase is also essential for chemoattractant-elicited depolarization of membrane potential and can regulate Ca 2+ , K + homeostasis in neutrophils (24). This may contribute to directional sensing in an indirect way. The exact mechanism by which ROS regulate neutrophil chemotaxis needs to be further investigated. During chemotaxis, many signaling events take place locally within the cell. For example, Rac-related signaling and actin polymerization are detected at the leading edge of chemotaxing cells, whereas RhoA activation and contractile actinmyosin complexes appear only at the back of the cells. Interestingly, we found NADPH oxidase was highly enriched near the leading edge of migrating neutrophils (Fig. S7 ). Whether this specific localization is essential for chemotaxis needs to be further investigated.
Experimental Procedures
Neutrophil Purification and Functional Assays. Human blood neutrophil purification, murine bone marrow neutrophil purification, quantification of F-actin levels by phalloidin labeling, measurement of superoxide production by luminol chemiluminescence, micropipette chemotaxis, and transwell migration assays were performed as described previously (25-27). Peripheral blood was obtained from a human CGD patient and healthy volunteer, with informed consent. EZ-TAXIScan chemotaxis assay, analysis of cell tracks and morphology, siRNA knockdown, and other related assays are described in SI Materials and Methods.
Recruitment of Adoptively Transferred Neutrophils in TG-Induced Peritonitis.
Peritonitis was induced as previously described (26). Neutrophils isolated from WT and CGD mice were labeled with intracellular fluorescent dye CFSE (final concentration, 1 μM; Molecular Probes) or 5-(and 6-) chloromethyl SNARF-1 acetate (final concentration, 1 μM; Molecular Probes) at 37°C for 10 min. Labeled cells were mixed as indicated in Fig. S6 then injected i.v. (via tail vein) into WT mice that have been challenged with 1 mL 3% TG for 2.5 h. Mice were euthanized by CO 2 inhalation 1.5 h after the injection of cell mixture (4 h after TG injection) and peritoneal exudate cells were recovered by peritoneal lavage with 10 mL of ice-cold PBS solution containing 5 mM EDTA. The amount of adoptively transferred neutrophils recruited to the peritoneal cavity was analyzed using a BD FACSCanto II flow cytometer (Becton Dickinson) and BD FACSDiva software. Relative recruitment of neutrophil was calculated as the ratio of indicated populations in the peritoneal cavity.
Recruitment of Adoptively Transferred Neutrophils in a Murine Dorsal Air Pouch Model. A dorsal air pouch was created by injecting mice with 5 mL of air s.c. on the back at d 0. On d 3 and 5, the pouches were reinflated with 2 mL of air. At 6 d after the initial air injection, TNF-α (in 0.5 mL sterile 0.9% saline solution) was directly injected into the pouch. Four hours after TNF-α injection, mice were anesthetized, and the pouch was flushed with 2 mL saline solution. The relative recruitment of WT and CGD neutrophils was calculated as described earlier.
Statistics. Analysis of statistical significance for indicated data sets was performed using the Student t test capability on Microsoft Excel. 
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SI Methods
Analysis of Cell Tracks and Morphology. (x,y) coordinates of migrating neutrophils (i.e., neutrophils that cross >65 μm from the starting line) were tracked from sequential images using DIAS imaging software (Solltech). Cell tracks were then realigned such that all of the cells started from the same starting point (0,0) and plotted using Matlab. Migration parameters are described in detail in Fig. S3 . Directionality and upward directionality were calculated as the straight-line migration distance from the origin divided by total migration length and straight-line distance migrated in the upward direction divided by total migration length (Fig. S3) . Migration speed (in μm/min) was calculated as average of cell speeds (migration distance between the current frame and the previous frame divided by the time between sequential frames, 0.5 min) at each captured frame. All parameters were calculated only for migrating cells in the 5 min to 15 min time frame of each movie. Percentage of neutrophils with multiple pseudopodia during the course of the 20-min video was evaluated from images of migrating cells. Fisher exact test (2 × 2) was performed to evaluate significant difference from untreated or WT neutrophils.
EZ-TAXIScan Chemotaxis Assay. The EZ-TAXIScan chamber (Effector Cell Institute) was assembled with a 260-μm-wide × 4-μm-thick silicon chip on a 2-mm untreated glass base, as described by the manufacturer and filled with RPMI/0.1% BSA. Inhibitor-treated (or carrier-treated) neutrophils (1 μL, 3 × 10 6 / mL) were added to the lower reservoir of each of the six channels and allowed to line up by removing 18 μL of buffer from the upper reservoir. RPMI/0.1% BSA (15 μL with the appropriate pharmacological inhibitor) was then added to fill both reservoirs to the brim. One microliter of chemoattractant (fMLP, C5a, or LTB4) was then added to the upper reservoir and neutrophil migration (at 37°C) in each of the channels was captured sequentially every 30 s for 20 min using a 10× lens on a Discovery Screening System (Universal Imaging). Pharmacological inhibitors (from Tocris Bioscience library) along with 200 nM of pan-PI3K inhibitor wortmannin (used to reduce random migration) were added directly to human neutrophils (100 μL, 3 × 10 6 / mL) in RPMI/0.1% BSA and incubated in a 37°C, 5% CO 2 chamber for 30 min before the chemotaxis assay.
CGD Mice. X-linked CGD mice (1) that contain disrupted alleles of the gene encoding gp91 phox (B6.129S6-Cybbtm1Din/J; strain, C57BL/6) were purchased from Jackson Laboratories. In all of the experiments performed with the CDG mice, we used C57BL/ 6 mice of the same age as WT controls. All procedures involving mice were approved and monitored by the Animal Care and Use Committee of Children's Hospital Boston.
Knockdown of p22
phox A predesigned duplexed Stealth siRNA (Invitrogen) that targets p22 phox (CYBA gene; accession no., NM_000101.2) was used to knock down p22 phox in dHL60 cells (sense sequence, ACU AUG UUC GGG CCG UCC UGC AUC U; antisense sequence, AGA UGC AGG ACG GCC CGA ACA UAG U). The negative control used was an ON-TARGETplus nontargeting siRNA 2 (Dharmacon). For gene silencing HL60 cells were differentiated for 1 d with 1.75% DMSO. On d 1, 2 × 10 6 cells were resuspended in 100 μL Cell Line V nucleofector solution, mixed with 1 μM siRNA (negative control or p22 phox ), and nucelofected using the T-019 program as per manufacturer instructions. Cells were then cultured in 2 mL IMDM plus 20% FBS plus 1.75% DMSO for 4 to 5 d, and then harvested for Western blotting, ROS production, and chemotaxis assays. Lysates of differentiated HL60 cells were probed for p22 phox expression using an anti-rabbit p22 phox antibody (Santa Cruz Biotechnology) and loading was evaluated using a GAPDH antibody (Encor Biotechnology). ROS production assays and EZ-TAXIScan chemotaxis assays were performed as described earlier. . Screening for pharmacological agents that modulate actin dynamics during neutrophil chemotaxis. (A) Cross-sectional schematic view of one of the six channels in EZ-TAXIScan device. The apparatus consists of a six-channel silicon chip (with two holes for each channel) pressed on top of a glass surface using a rubber gasket and metal holder. Cells (1 μL) are loaded to the bottom of one reservoir and chemoattractant (1 μL) is added to the other reservoir. This sets up a chemoattractant gradient between the reservoirs, driving cells to migrate toward the chemoattractant reservoir through a narrow gap (4 μm height, 260 μm length) between the silicon chip and glass surface. Images of migrating cells in each of the six channels are captured in parallel using a 10× lens coupled to a CCD camera. (B) Chemotaxis of human neutrophils in response to chemoattractant fMLP. Human neutrophils (3,000 cells) were plated into the neutrophil reservoir (bottom well) of the EZ-TAXIScan device and exposed to no chemoattractant (Left) or to a chemoattractant gradient (Right) generated by addition of 100 nM fMLP (1 μL) into the chemoattractant reservoir (top well). Images of neutrophils are shown at 0 min, 10 min, and 20 min after chemoattractant addition. Fig. S2 . Biologically active pharmacological agents that decrease chemotaxis efficiency of human neutrophils. Neutrophils were incubated at 37°C for 30 min without any treatment or with the following pharmacological agents: 2,4-diamino-6-hydroxypyrimidine (DAHP; 300 μM), GF 109203X (58 μM), dibutyryl-cAMP (1 mM), SKF 96365 hydrochloride (56 μM), nocodazole (16 μM), vinblastine sulfate (1.78 μM), DPI (100 μM), colchicine (10 μM), D-6413 (0.74 μM), EHNA hydrochloride (40 μM), 2-methoxyestradiol (19 μM), and LE 135 (14 μM). They were then exposed to a chemoattractant gradient generated by addition of 100 nM fMLP (1 μL) in the EZ-TAXIScan device and imaged every 0.5 min for 20 min. (A) Cell tracks of untreated and drug treated migrating neutrophils (cells that move ≥65 μm from the bottom of the channel; n = 20) were traced from the captured images, realigned such that all cells started from the same starting point (0,0), and plotted. Chemoattractant concentration increases in the positive y direction. (B and C) Cell tracks of migrating neutrophils in the 5 min to 15 min time frame were analyzed as described in Experimental Procedures to determine directionality (0-1) (B), defined as straight-line migration distance from the origin divided by the total migration length; and upward directionality (−1 to 1) (C), defined as straight-line distance migrated in the upward direction divided by total migration length (Fig. S3) . Data in B and C are represented as mean ± SD for 20 cells. (*P < 0.05 versus untreated neutrophils.) Fig. S3 . Chemotaxis parameters for neutrophil migration in response to a chemoattractant gradient. If n is the number of successive frames analyzed and (xn, yn, tn) denotes the position of the neutrophil (xn, yn) at any time tn, the chemotaxis parameters can be calculated as follows: directionality (0-1) is dS / (d1 + d2 . . .+ df), speed (μm/min) is (d1 / (t1 − t0) + d2 / (t2 − t1) + . . .+ df / (tf − t3)) / n, and upward directionality (−1 to 1) is dU / (d1 + d2 . . .+ df). Here, "f" denotes the final position of the cell, "0" denotes the initial position, dn is the distance migrated between two successive frames (xn, yn) and (xn-1, yn-1), dS is the straight-line migration distance, i.e., distance between (x0, y0) and (xf, yf), and dU is the straight-line migration distance in the direction of the chemoattractant gradient (upward), i.e., distance between (x0, y0) and (x0, yf), yf-y0. . NADPH oxidase is enriched near the leading edge of chemotaxing neutrophils. Purified human neutrophils were washed once with HBSS with calcium and magnesium, and were plated onto glass coverslips coated with 10 μg/mL fibronectin for 10 min at 37°C. Neutrophils were then stimulated with 100 nM fMLP for indicated time, fixed with 6% paraformaldehyde/PBS solution for 5 min at room temperature, and washed three times with PBS solution. Neutrophils were then permeabilized with 0.2% Triton-X in PBS solution for 10 min at room temperature and then preblocked with PBS solution/1% BSA blocking buffer for 15 min at room temperature. Primary antibody (1:1,000; rabbit anti-p22 subunit of NADPH oxidase) was then added to the fixed cells in the blocking buffer for 1 h, washed three times with PBS solution, followed by incubation with secondary antibodies (1:1,000; Alexa 488-conjugated anti-rabbit IgG) for 30 min and three washes with PBS solution. The distribution of p22 was imaged in the FITC channel. (+/-)-Palmitoylcarnitine chloride Protein kinase C inhibitor 30µM cell death cell death cell death no effect no effect no effect 1B11 Verapamil hydrochloride Ca2+ channel blocker (L-type) 62µM cell death cell death no effect no effect no effect no effect 2C2 Diltiazem hydrochloride Ca2+ channel blocker (L-type) 320µM cell death cell death cell death no effect no effect no effect 2C7 Glibenclamide K+ channel blocker (KATP)/CFTR Cl-channel blocker 20µM cell death completely inhibited partially inhibited no effect no effect no effect 2F8 Tamoxifen citrate Oestrogen receptor partial agonist / antagonist 8µM cell death cell death slow & long-tailed no effect no effect no effect 2 E10 Tranilast Anti-allergic, inhibits release from mast cells(anti-AT1 receptor?) 100µM cell death no effect no effect no effect no effect no effect 3D4 A23187 Calcium ionophore 1.9µM cell death cell death cell death cell death cell death cell death 3C11 PACOCF3 Phospholipase A2 inhibitor 3.8µM cell death cell death no effect no effect no effect no effect 4G3 Splitomicin Histone deacetylase (Sir2p) inhibitor 60µM cell death no effect no effect no effect no effect no effect 4C6 AY 9944 dihydrochloride Inhibitor of hedgehog (hh) signaling. Inhibits D7-dehydrocholesterol reductase 210µM cell death cell death cell death completely inhibited no effect no effect 5A2 m-3M3FBS Phospholipase C activator 10µM cell death no effect no effect no effect no effect no effect 5F6 Embelin Cell-permeable inhibitor of X-linked inhibitor of apoptosis (XIAP) 4.1µM cell death cell death no effect no effect no effect no effect 5D8 Leflunomide Immunosuppressant agent. 100µM cell death cell death cell death no effect no effect no effect Supplemental Table 4 . Drugs that affect neutrophil chemotaxis . The movie files for each compound will be released to a public database after the publication of this paper. Myosin light chain kinase inhibitor 4µM completely inhibited slow migration slow migration no effect no effect
1G6 Flunarizine dihydrochloride
Dual Na+ / Ca2+ channel (T-type) blocker 4µM slow & long-tailed no effect no effect no effect no effect Protein kinase C inhibitor 1.1µM slow migration no effect no effect no effect no effect
1A7

2F3 Ceramide
Ser / Thr protein phosphatase activator 6µM completely inhibited slow migration slow migration no effect no effect
2A4 Dihydrosphingosine
Protein kinase C inhibitor 2µM slow migration slow migration no effect no effect no effect
2C4 Vinpocetine
Phosphodiesterase(PDE1) inhibitor/Na+ channel blocker 21µM slow migration slow migration no effect no effect no effect 3A3 PD 98059
Specific inhibitor of MEK 7µM slightly long tailed slightly long-tailed no effect no effect no effect 3C3 2APB
Membrane permeable IP3 receptor antagonist 42µM very slow migration slow & long-tailed long-tailed no effect no effect Selective inhibitor of BTK(Bruton's tyrosine kinase) 30µM slow migration no effect no effect no effect no effect
3D10 DCEBIO
Activates Cl-conductance and hIK1 K+ channels 60µM partially inhibited long-tailed long-tailed long-tailed no effect
4C4 Cantharidin
Protein phosphatase 1 and 2A inhibitor 1.1µM slow migration slow migration no effect no effect no effect Interleukin-5 receptor antagonist 1µM slow & long-tailed long-tailed no effect no effect no effect
4B8 Sulindac
Cyclooxygenase inhibitor (following metabolism to sulindac sulfide) 100µM completely inhibited completely inhibited very slow migration slow & long-tailed slow migration
Selective inhibitor of nonmuscle myosin II 2µM slow & long-tailed slow & long-tailed no effect no effect no effect
4G9
Ro 106-9920
Inhibitor of NF-kB activation 3µM completely inhibited very slow migration slow migration slightly slow no effect Selective inhibitor of skeletal muscle myosin II ATPase activity 5µM slow migration slightly slow no effect no effect no effect
E3 Linopirdine dihydrochloride
Blocker of KCNQ voltage-gated potassium channels.(KCNQ1, KCNQ2+3) 8.9µM slow migration no effect no effect no effect no effect 5G3 Ro 31-8220 mesylate Protein kinase C inhibitor, with activity at other protein kinases 38nM slow & long-tailed slow migration slower migration no effect no effect 5D6 API-2
Selective inhibitor of Akt (protein kinase B) signaling 46µM slow migration slow migration no effect no effect no effect 5G6 Bax channel blocker Potent inhibitor of Bax-mediated mitochondrial cytochrome c release 520nM slow & long-tailed slow & long-tailed no effect no effect no effect 5B7 BVT 948
Non-competitive, cell permeable inhibitor of protein tyrosine phosphatases 7.1µM slow at first slow at first slow at first no effect no effect
E7 NSC 146109 hydrochloride
Cell-permeable antitumour agent that activates p53-dependent transcription 15.8µM cell death cell death cell death slow migration slow migration 5H7 R 59-022
Diacylglycerol kinase inhibitor 2.8µM slow migration slow migration no effect no effect no effect 3G10 D609
Selective PC-PLC inhibitor 75µM partially inhibited partially inhibited partially inhibited partially inhibited no effect
E3 DCPIB
Potent, selective blocker of the volume-sensitive anion channel (VSAC) 4.1µM partially inhibited partially inhibited partially inhibited partially inhibited partially inhibited 5H6
INCA-6
Inhibitor of interaction between calcineurin and its substrate NFAT 800nM partially inhibited partially inhibited partially inhibited no effect no effect Protein kinase C activator 100µM cell death completely inhibited completely inhibited completely inhibited no effect
1H4 Capsazepine
Vanilloid receptor antagonist. 3.2µM completely inhibited partially inhibited no effect no effect no effect
1H8 Nimodipine
Ca2+ channel blocker (L-type) 60µM cell death completely inhibited completely inhibited partially inhibited partially inhibited
1A9 Nitrendipine
Ca2+ channel blocker (L-type) 30µM completely inhibited completely inhibited partially inhibited no effect no effect 2A2 NPC 15199
Novel anti-inflammatory agent 36µM completely inhibited completely inhibited completely inhibited no effect no effect Anticancer, antifertility agent 7µM completely inhibited partially inhibited no effect no effect no effect 5D5 RS 102895 hydrochloride CCR2b-selective chemokine receptor antagonist 17.8µM completely inhibited slow migration no effect no effect no effect 5G5 Apoptosis Activator 2
2G4
Apoptosis activator 9µM completely inhibited partially inhibited no effect no effect no effect Protein kinase C inhibitor(α/β1/γ/δ/ε/ζ subtypes) 5.8µM completely inhibited head shaking random movement multiple pseudopods no effect 3B2 Dibutyryl-cAMP, sodium salt Cell-permeable cAMP analogue 100µM head shaking slightly head shaking no effect no effect no effect 3D2 SKF 96365 hydrochloride
Receptor-operated calcium channel blocker 11.2µM random movement random movement random movement no effect no effect
3F3 Nocodazole
Microtubule inhibitor 3.2µM long-tailed multiple pseudopod multiple pseudopod random movement random movement
3H4
Vinblastine sulfate Disrupts microtubules 178nM slightly random slight random slightly random slightly random no effect 3D5 EHNA hydrochloride
Adenosine deaminase inhibitor 4µM multiple pseudopods multiple pseudopods slow migration no effect no effect
3A8 Colchicine
Inhibitor of tubulin 1µM random movement slightly random slightly random slightly random slightly random 4D6 D-64131
Inhibitor of tubulin polymerization. Antitumour in vivo 74nM random movement slightly random no effect no effect no effect 4C10
2-Methoxyestradiol
Apoptotic and antiangiogenic agent (inhibits tubulinpolymerization) 1.9µM random movement no effect no effect no effect no effect
E4 LE 135
Retinoic acid antagonist 1.4µM multiple pseudopods multiple pseudopods multiple pseudopods multiple pseudopods multiple pseudopods
